ALBENDAZOLE

ALBENDAZOLE was reported 1904 times

ALBENDAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY ECHINOCOCCIASIS 3 0.5000
1 POTASSIUM HYDROXIDE PREPARATION POSITIVE 3 0.5000
2 MAZZOTTI REACTION 4 0.3636
3 ILEUS SPASTIC 2 0.3333
4 STEROID DEPENDENCE 159 0.1811
5 ECHINOCOCCIASIS 12 0.1644
6 CATARRH 134 0.1482
7 CONGENITAL ABSENCE OF CRANIAL VAULT 8 0.1379
8 NEUROCYSTICERCOSIS 6 0.1333
9 DERMATOPHAGIA 1 0.1250
10 MYOCARDITIS TOXOPLASMAL 2 0.1176
11 BIFIDOBACTERIUM INFECTION 3 0.1111
12 CONGENITAL HEART VALVE INCOMPETENCE 1 0.1111
13 BALAMUTHIA INFECTION 3 0.1034
14 TAENIASIS 4 0.0952
15 HELMINTHIC INFECTION 23 0.0947
16 ISOSPORIASIS 7 0.0897
17 FOLLICULAR DISORDER 3 0.0833
18 BURNS SECOND DEGREE 138 0.0786
19 TOXOCARIASIS 3 0.0750
20 ANORECTAL VARICES 3 0.0714
21 DISSEMINATED STRONGYLOIDIASIS 15 0.0685
22 HAEMOSIDEROSIS 18 0.0672
23 ASCARIASIS 2 0.0606
24 HEPATIC ECHINOCOCCIASIS 3 0.0600
25 ALCOHOLIC COMA 1 0.0588
26 STRONGYLOIDIASIS 74 0.0458
27 HYPOPNOEA 137 0.0394
28 ALCOHOL POISONING 85 0.0317
29 HERPES SIMPLEX MENINGITIS 2 0.0282
30 ABORTION SPONTANEOUS COMPLETE 1 0.0256
31 SUPERFICIAL INFLAMMATORY DERMATOSIS 3 0.0244
32 BRONCHIECTASIS 157 0.0233
33 MICROSPORIDIA INFECTION 8 0.0228
34 ENTEROCOCCAL SEPSIS 18 0.0222
35 CATHETER SITE PHLEBITIS 1 0.0192
36 PAROSMIA 133 0.0176
37 RHINITIS 140 0.0173
38 GINGIVAL PAIN 137 0.0172
39 IRON OVERLOAD 18 0.0167
40 VANISHING BILE DUCT SYNDROME 18 0.0161
41 CARDIAC MURMUR 138 0.0159
42 ANTI-HBS ANTIBODY POSITIVE 1 0.0156
43 AUTOIMMUNE UVEITIS 1 0.0152
44 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 5 0.0149
45 CYST RUPTURE 10 0.0147
46 CYTOMEGALOVIRUS MUCOCUTANEOUS ULCER 1 0.0139
47 ERYTHEMA ANNULARE 4 0.0138
48 CESTODE INFECTION 1 0.0137
49 EXTRAPULMONARY TUBERCULOSIS 4 0.0136
50 MENINGOENCEPHALITIS BACTERIAL 2 0.0135
51 INFECTION PARASITIC 10 0.0128
52 AORTIC VALVE THICKENING 2 0.0124
53 BLASTOCYSTIS INFECTION 1 0.0115
54 CEREBRAL MASS EFFECT 4 0.0110
55 NEURAL TUBE DEFECT 8 0.0110
56 HEPATORENAL SYNDROME 18 0.0107
57 CILIARY HYPERAEMIA 1 0.0105
58 PARASITIC GASTROENTERITIS 2 0.0104
59 MEAN PLATELET VOLUME DECREASED 8 0.0095
60 IMPAIRED QUALITY OF LIFE 136 0.0095
61 EXTRAOCULAR MUSCLE DISORDER 3 0.0093
62 CNS VENTRICULITIS 3 0.0092
63 BODY TINEA 5 0.0089
64 BLOOD PRESSURE 2 0.0084
65 CONGENITAL SKIN DIMPLES 2 0.0083
66 PITTING OEDEMA 5 0.0082
67 ABDOMINAL LYMPHADENOPATHY 7 0.0081
68 LYMPHANGITIS 6 0.0075
69 HEPATITIS TOXIC 19 0.0073
70 TUBULOINTERSTITIAL NEPHRITIS 136 0.0072
71 INTENTION TREMOR 4 0.0070
72 IMPAIRED WORK ABILITY 145 0.0068
73 CSF CELL COUNT INCREASED 1 0.0068
74 KNEE DEFORMITY 10 0.0067
75 MESENTERIC PANNICULITIS 2 0.0067
76 NEUROPSYCHOLOGICAL SYMPTOMS 4 0.0066
77 BILIARY FISTULA 1 0.0065
78 ADAMS-STOKES SYNDROME 1 0.0065
79 CEREBRAL TOXOPLASMOSIS 6 0.0064
80 SUPERINFECTION BACTERIAL 5 0.0063
81 ACUTE TONSILLITIS 1 0.0063
82 CONGENITAL HEARING DISORDER 1 0.0062
83 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
84 FREQUENT BOWEL MOVEMENTS 157 0.0058
85 MONOCYTE COUNT DECREASED 7 0.0057
86 PNEUMONITIS CHEMICAL 2 0.0057
87 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
88 BLOOD ZINC DECREASED 1 0.0055
89 MENINGITIS PNEUMOCOCCAL 2 0.0055
90 MENINGITIS TUBERCULOUS 3 0.0054
91 ANAL PRURITUS 11 0.0053
92 AEROMONAS INFECTION 1 0.0053
93 BACTERIA STOOL IDENTIFIED 1 0.0053
94 CHEMICAL PERITONITIS 1 0.0051
95 BIRTH MARK 1 0.0048
96 BRONCHOALVEOLAR LAVAGE ABNORMAL 1 0.0048
97 CLOSTRIDIUM BACTERAEMIA 1 0.0047
98 AUTOMATISM 1 0.0046
99 SWOLLEN TONGUE 135 0.0043
100 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
101 CD4 LYMPHOCYTES INCREASED 1 0.0043
102 MALARIA 3 0.0043
103 AMOEBIASIS 1 0.0043
104 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
105 CEREBRAL MICROANGIOPATHY 1 0.0042
106 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 7 0.0042
107 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
108 ACUTE GRAFT VERSUS HOST DISEASE 19 0.0041
109 RENAL TRANSPLANT FAILURE 4 0.0040
110 NIGHTMARE 136 0.0039
111 SYSTEMIC LUPUS ERYTHEMATOSUS 139 0.0039
112 CORNEAL THINNING 1 0.0039
113 ACCIDENTAL OVERDOSE 138 0.0038
114 CEREBRAL CALCIFICATION 1 0.0037
115 RECTAL HAEMORRHAGE 161 0.0037
116 HYPEREOSINOPHILIC SYNDROME 2 0.0037
117 CAPILLARITIS 1 0.0036
118 COLITIS ULCERATIVE 161 0.0036
119 LIP ULCERATION 4 0.0034
120 RENAL TUBULAR ATROPHY 3 0.0034
121 CONJUNCTIVAL HYPERAEMIA 12 0.0034
122 GRUNTING 2 0.0033
123 ENCEPHALITIS 23 0.0033
124 OROPHARYNGEAL CANDIDIASIS 3 0.0033
125 CORNEAL LESION 1 0.0032
126 BLOOD ELECTROLYTES ABNORMAL 4 0.0032
127 XEROSIS 4 0.0032
128 SCROTAL SWELLING 3 0.0032
129 WOUND COMPLICATION 11 0.0032
130 DRUG LEVEL CHANGED 2 0.0032
131 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
132 TESTICULAR SWELLING 4 0.0032
133 CHRONIC HEPATITIS B 1 0.0032
134 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 151 0.0031
135 APPLICATION SITE OEDEMA 1 0.0031
136 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
137 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
138 HAEMATOCHEZIA 168 0.0030
139 TINNITUS 139 0.0030
140 DERMOID CYST 1 0.0030
141 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 2 0.0029
142 CEREBRAL CYST 2 0.0029
143 DEATH NEONATAL 4 0.0029
144 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
145 DELAYED GRAFT FUNCTION 2 0.0028
146 MEDICATION ERROR 155 0.0028
147 TOXOPLASMOSIS 3 0.0028
148 SYMPTOM MASKED 2 0.0027
149 ANAESTHESIA 1 0.0027
150 GENITAL PAIN 4 0.0027
151 ANASTOMOTIC STENOSIS 1 0.0027
152 DELUSIONAL DISORDER, UNSPECIFIED TYPE 2 0.0027
153 SUPERINFECTION 4 0.0027
154 KLEBSIELLA SEPSIS 3 0.0027
155 BRONCHOPLEURAL FISTULA 1 0.0027
156 PERFORATED ULCER 2 0.0026
157 ECZEMA 138 0.0026
158 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
159 GENITAL ULCERATION 2 0.0026
160 PRURITUS GENITAL 6 0.0025
161 ARACHNOID CYST 1 0.0025
162 DISSEMINATED MUCORMYCOSIS 1 0.0025
163 VERTIGO 154 0.0025
164 ENCEPHALITIS VIRAL 3 0.0025
165 LARGE INTESTINE INFECTION 3 0.0024
166 SELF-MEDICATION 10 0.0024
167 DEEP VEIN THROMBOSIS 158 0.0024
168 ALVEOLAR OSTEITIS 1 0.0024
169 MENINGITIS CRYPTOCOCCAL 4 0.0023
170 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
171 POSTPARTUM HAEMORRHAGE 3 0.0022
172 NUCHAL RIGIDITY 2 0.0022
173 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
174 MENINGITIS VIRAL 3 0.0022
175 CEREBRAL HYPOPERFUSION 1 0.0021
176 PERIPHERAL ARTERY THROMBOSIS 3 0.0021
177 KLEBSIELLA BACTERAEMIA 2 0.0021
178 MENINGITIS BACTERIAL 3 0.0021
179 BLINDNESS CORTICAL 1 0.0020
180 IDIOSYNCRATIC DRUG REACTION 2 0.0020
181 ABORTION THREATENED 1 0.0020
182 DYSGEUSIA 138 0.0019
183 ACARODERMATITIS 2 0.0018
184 PNEUMONIA STREPTOCOCCAL 2 0.0018
185 INTENTIONAL PRODUCT USE ISSUE 158 0.0018
186 ARTHRITIS 141 0.0018
187 KLEBSIELLA INFECTION 9 0.0018
188 BACTERIURIA 1 0.0018
189 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
190 PRURITUS ALLERGIC 2 0.0017
191 KYPHOSIS 3 0.0017
192 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
193 RETINAL VASCULITIS 2 0.0017
194 PNEUMONIA INFLUENZAL 2 0.0017
195 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
196 CHEILITIS 9 0.0017
197 MIXED LIVER INJURY 5 0.0017
198 BLOOD VISCOSITY INCREASED 1 0.0017
199 LYMPHADENITIS 4 0.0017
200 PENILE SWELLING 2 0.0016
201 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
202 OCULAR ICTERUS 7 0.0016
203 DERMATOSIS 1 0.0016
204 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
205 WHITE MATTER LESION 2 0.0016
206 CHORIORETINITIS 1 0.0016
207 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
208 SINUS ARRHYTHMIA 2 0.0015
209 ADVERSE DRUG REACTION 137 0.0015
210 DERMATITIS BULLOUS 11 0.0015
211 EMPYEMA 3 0.0015
212 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
213 CHOREOATHETOSIS 1 0.0015
214 HYDROCEPHALUS 8 0.0015
215 HYPOVOLAEMIC SHOCK 7 0.0015
216 MIGRAINE 139 0.0015
217 STILLBIRTH 7 0.0014
218 TOXIC EPIDERMAL NECROLYSIS 22 0.0014
219 ENTEROCOCCAL INFECTION 7 0.0014
220 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
221 PULMONARY EMBOLISM 137 0.0014
222 GASTROENTERITIS 21 0.0014
223 THERAPEUTIC PROCEDURE 2 0.0014
224 PULMONARY TUBERCULOSIS 6 0.0014
225 DERMATITIS EXFOLIATIVE 7 0.0014
226 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
227 AMNIOTIC CAVITY INFECTION 1 0.0014
228 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
229 BACTERIAL DISEASE CARRIER 1 0.0014
230 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
231 GENERALISED ANXIETY DISORDER 2 0.0014
232 TRANSAMINASES INCREASED 30 0.0013
233 BRAIN STEM SYNDROME 1 0.0013
234 STEROID DIABETES 2 0.0013
235 HEPATOCELLULAR DAMAGE 3 0.0013
236 COMPLICATION OF PREGNANCY 1 0.0013
237 DIAPHRAGMATIC DISORDER 1 0.0013
238 PALPITATIONS 152 0.0013
239 CRITICAL ILLNESS 1 0.0013
240 ESCHERICHIA BACTERAEMIA 3 0.0013
241 MEGACOLON 2 0.0013
242 DIARRHOEA INFECTIOUS 1 0.0013
243 ASPERGILLUS INFECTION 8 0.0012
244 SEPTIC SHOCK 53 0.0012
245 STEVENS-JOHNSON SYNDROME 27 0.0012
246 CSF PROTEIN INCREASED 1 0.0012
247 DEPERSONALISATION 1 0.0012
248 MENINGITIS 8 0.0012
249 CEREBELLAR INFARCTION 2 0.0012
250 ENCEPHALOPATHY 29 0.0012
251 GASTRITIS 31 0.0012
252 ALLERGIC SINUSITIS 1 0.0012
253 MYCOBACTERIAL INFECTION 2 0.0012
254 PRODUCT COUNTERFEIT 2 0.0012
255 KIDNEY FIBROSIS 2 0.0012
256 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 63 0.0011
257 ABDOMINAL SEPSIS 1 0.0011
258 ANGIONEUROTIC OEDEMA 3 0.0011
259 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
260 BLOOD MAGNESIUM INCREASED 1 0.0011
261 LARGE INTESTINAL ULCER 3 0.0011
262 DEFORMITY 10 0.0011
263 ABORTION INDUCED 10 0.0011
264 HEPATIC NECROSIS 4 0.0011
265 CEREBRAL PALSY 1 0.0011
266 GENERALISED OEDEMA 13 0.0010
267 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
268 BRAIN OEDEMA 13 0.0010
269 EOSINOPHILIA 18 0.0010
270 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
271 BONE MARROW DEPRESSION 1 0.0010
272 BICYTOPENIA 2 0.0010
273 CELL DEATH 2 0.0010
274 CREPITATIONS 3 0.0010
275 OESOPHAGEAL CANDIDIASIS 4 0.0010
276 METABOLIC ENCEPHALOPATHY 3 0.0010
277 EMPHYSEMA 10 0.0010
278 DUODENITIS 3 0.0010
279 CONJUNCTIVAL OEDEMA 1 0.0010
280 PRODUCT USE IN UNAPPROVED INDICATION 239 0.0010
281 AXILLARY MASS 1 0.0010
282 UTERINE LEIOMYOMA 7 0.0010
283 CONFUSIONAL STATE 153 0.0009
284 TESTICULAR PAIN 3 0.0009
285 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 1 0.0009
286 ABDOMINAL DISCOMFORT 155 0.0009
287 BACTERIAL SEPSIS 3 0.0009
288 NORMAL NEWBORN 5 0.0009
289 SKIN LACERATION 10 0.0009
290 BLADDER DILATATION 1 0.0009
291 HENOCH-SCHONLEIN PURPURA 2 0.0009
292 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
293 FOOT DEFORMITY 10 0.0009
294 FAECES PALE 2 0.0009
295 PARESIS 2 0.0009
296 INTRACRANIAL PRESSURE INCREASED 5 0.0009
297 CALCINOSIS 2 0.0009
298 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
299 BLOOD BILIRUBIN INCREASED 24 0.0009
300 TONGUE ULCERATION 3 0.0009
301 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 160 0.0009
302 PNEUMOTHORAX 14 0.0009
303 BRAIN OPERATION 2 0.0009
304 BRONCHOPNEUMONIA 3 0.0009
305 HEPATIC CYTOLYSIS 11 0.0009
306 HYPERTRANSAMINASAEMIA 6 0.0009
307 YELLOW SKIN 4 0.0009
308 SOMNOLENCE 171 0.0008
309 ACUTE LUNG INJURY 1 0.0008
310 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
311 EOSINOPHIL COUNT INCREASED 7 0.0008
312 CEREBROVASCULAR ACCIDENT 142 0.0008
313 ODYNOPHAGIA 5 0.0008
314 SKIN PLAQUE 7 0.0008
315 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
316 EYE OEDEMA 2 0.0008
317 PARADOXICAL DRUG REACTION 3 0.0008
318 SPRUE-LIKE ENTEROPATHY 4 0.0008
319 COVID-19 142 0.0008
320 ACUTE PSYCHOSIS 2 0.0008
321 TENDON INJURY 3 0.0008
322 ABDOMINAL TENDERNESS 4 0.0008
323 HYPERNATRAEMIA 4 0.0008
324 THROAT CLEARING 3 0.0008
325 TOXIC ENCEPHALOPATHY 4 0.0008
326 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
327 ABDOMINAL INFECTION 2 0.0008
328 DISSEMINATED TUBERCULOSIS 2 0.0008
329 HEPATOSPLENOMEGALY 2 0.0008
330 HELICOBACTER INFECTION 8 0.0008
331 CACHEXIA 4 0.0008
332 BILIARY OBSTRUCTION 1 0.0008
333 HEPATITIS ACUTE 5 0.0008
334 LUNG OPACITY 2 0.0008
335 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
336 BACTERAEMIA 9 0.0008
337 PREMATURE DELIVERY 12 0.0008
338 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
339 CONDITION AGGRAVATED 227 0.0007
340 JOINT RANGE OF MOTION DECREASED 10 0.0007
341 JAUNDICE 20 0.0007
342 DRUG-INDUCED LIVER INJURY 23 0.0007
343 ABSCESS ORAL 1 0.0007
344 CORNEAL ABRASION 1 0.0007
345 CHOLESTASIS 14 0.0007
346 CYTOMEGALOVIRUS INFECTION 12 0.0007
347 LARGE INTESTINE POLYP 5 0.0007
348 RASH MORBILLIFORM 2 0.0007
349 DISCHARGE 1 0.0007
350 AUTOIMMUNE HEPATITIS 5 0.0007
351 PYREXIA 247 0.0007
352 HYPERPYREXIA 3 0.0007
353 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
354 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
355 DIVERTICULUM 5 0.0007
356 PHARYNGEAL DISORDER 2 0.0007
357 EXPOSURE DURING PREGNANCY 43 0.0007
358 ABASIA 17 0.0007
359 NEUTROPHIL COUNT INCREASED 7 0.0007
360 ORAL CANDIDIASIS 9 0.0007
361 APRAXIA 1 0.0007
362 HEPATITIS FULMINANT 2 0.0007
363 ABORTION SPONTANEOUS 27 0.0007
364 HEPATOTOXICITY 15 0.0007
365 AXILLARY PAIN 1 0.0007
366 ILEUS PARALYTIC 3 0.0007
367 THERAPY NON-RESPONDER 30 0.0007
368 ACUTE HEPATIC FAILURE 9 0.0007
369 DEPRESSION 149 0.0007
370 BLOOD PRESSURE IMMEASURABLE 1 0.0007
371 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
372 CYST 8 0.0006
373 PANCYTOPENIA 36 0.0006
374 WEIGHT DECREASED 178 0.0006
375 HEPATOCELLULAR INJURY 9 0.0006
376 LOW BIRTH WEIGHT BABY 5 0.0006
377 MALNUTRITION 7 0.0006
378 KIDNEY TRANSPLANT REJECTION 3 0.0006
379 PROCTALGIA 4 0.0006
380 CRYPTOCOCCOSIS 1 0.0006
381 ASPHYXIA 5 0.0006
382 DEAFNESS NEUROSENSORY 2 0.0006
383 EYELID OEDEMA 7 0.0006
384 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
385 SPINAL FRACTURE 12 0.0006
386 AGRANULOCYTOSIS 11 0.0006
387 PRODUCT TASTE ABNORMAL 8 0.0006
388 BLOOD PH DECREASED 1 0.0006
389 BLOOD AMYLASE INCREASED 1 0.0006
390 SKIN HYPERPIGMENTATION 5 0.0006
391 ACUTE SINUSITIS 1 0.0006
392 BLOOD CHLORIDE INCREASED 1 0.0006
393 MYOPATHY 5 0.0006
394 SKIN NECROSIS 3 0.0006
395 HYPERREFLEXIA 2 0.0006
396 SEDATION 15 0.0006
397 PAPULE 4 0.0006
398 COMA 27 0.0006
399 NYSTAGMUS 3 0.0006
400 GLOSSITIS 2 0.0006
401 PATHOGEN RESISTANCE 5 0.0005
402 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
403 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
404 DRUG LEVEL INCREASED 9 0.0005
405 DIFFUSE ALOPECIA 1 0.0005
406 PLATELET COUNT INCREASED 7 0.0005
407 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
408 BLOOD BICARBONATE DECREASED 1 0.0005
409 GENERALISED ERYTHEMA 3 0.0005
410 DERMATITIS 11 0.0005
411 ACUTE RESPIRATORY FAILURE 10 0.0005
412 ENTEROCOLITIS 3 0.0005
413 CLEFT PALATE 1 0.0005
414 ELECTROLYTE IMBALANCE 6 0.0005
415 PANIC DISORDER 2 0.0005
416 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
417 ALCOHOL INTERACTION 1 0.0005
418 NEUROTOXICITY 9 0.0005
419 ABDOMINAL WALL HAEMATOMA 1 0.0005
420 APLASIA 1 0.0005
421 SKIN LESION 14 0.0005
422 LYMPHOCYTE COUNT DECREASED 9 0.0005
423 PROSTATOMEGALY 2 0.0005
424 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
425 PNEUMONIA FUNGAL 2 0.0005
426 INABILITY TO AFFORD MEDICATION 5 0.0005
427 PAIN IN EXTREMITY 148 0.0005
428 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
429 CARDIAC DISCOMFORT 1 0.0005
430 FUNGAL SKIN INFECTION 2 0.0005
431 ENURESIS 2 0.0005
432 ESCHERICHIA INFECTION 4 0.0005
433 ANAPHYLACTOID REACTION 2 0.0005
434 HYPERBILIRUBINAEMIA 5 0.0005
435 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
436 POISONING 6 0.0005
437 SKIN ULCER 12 0.0005
438 INCOHERENT 3 0.0005
439 HEPATIC LESION 2 0.0005
440 PRURITUS GENERALISED 10 0.0005
441 SKIN SWELLING 4 0.0005
442 SOMNAMBULISM 3 0.0005
443 CORNEAL DISORDER 1 0.0005
444 ONYCHOMYCOSIS 2 0.0005
445 DIABETIC NEPHROPATHY 1 0.0005
446 HAEMATOCRIT DECREASED 9 0.0005
447 IMMUNOSUPPRESSION 4 0.0005
448 ABDOMINAL ABSCESS 2 0.0005
449 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
450 RESPIRATORY RATE INCREASED 4 0.0005
451 SKIN MASS 3 0.0004
452 RENAL FAILURE ACUTE 19 0.0004
453 CYANOSIS 7 0.0004
454 URINARY TRACT DISORDER 2 0.0004
455 CHRONIC GASTRITIS 1 0.0004
456 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
457 URINE ABNORMALITY 2 0.0004
458 ABSCESS 7 0.0004
459 DISLOCATION OF VERTEBRA 1 0.0004
460 EYE MOVEMENT DISORDER 3 0.0004
461 IMMUNE THROMBOCYTOPENIA 2 0.0004
462 DENGUE FEVER 1 0.0004
463 RESPIRATORY DISTRESS 12 0.0004
464 UROSEPSIS 4 0.0004
465 APHTHOUS STOMATITIS 1 0.0004
466 GRAND MAL CONVULSION 4 0.0004
467 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
468 BILIRUBIN CONJUGATED INCREASED 1 0.0004
469 RESPIRATORY FAILURE 31 0.0004
470 PULSE ABSENT 2 0.0004
471 NEUTROPENIC SEPSIS 3 0.0004
472 DIABETES INSIPIDUS 1 0.0004
473 RASH VESICULAR 2 0.0004
474 GUILLAIN-BARRE SYNDROME 2 0.0004
475 ORAL DISORDER 3 0.0004
476 LIVER INJURY 10 0.0004
477 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
478 RASH 176 0.0004
479 HYPOTONIA 4 0.0004
480 LEUKOPENIA 20 0.0004
481 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
482 CHROMATURIA 9 0.0004
483 BONE MARROW FAILURE 8 0.0004
484 HYPOKALAEMIA 18 0.0004
485 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
486 ANOREXIA 5 0.0004
487 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
488 APNOEA 3 0.0004
489 EYE DISCHARGE 4 0.0004
490 APLASTIC ANAEMIA 2 0.0004
491 BLOOD LACTIC ACID INCREASED 2 0.0004
492 DISEASE RECURRENCE 18 0.0004
493 METABOLIC ACIDOSIS 12 0.0004
494 HEADACHE 235 0.0004
495 PRODUCT RESIDUE PRESENT 2 0.0004
496 BLOOD SODIUM INCREASED 1 0.0004
497 SEPSIS 41 0.0004
498 CONVULSION 21 0.0004
499 INTESTINAL ISCHAEMIA 2 0.0004
500 DYSTONIA 7 0.0004
501 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
502 C-REACTIVE PROTEIN INCREASED 13 0.0004
503 ANAL HAEMORRHAGE 1 0.0004
504 FACIAL PARALYSIS 3 0.0004
505 NEUROLOGICAL SYMPTOM 2 0.0003
506 PSEUDOMONAS INFECTION 3 0.0003
507 OFF LABEL USE 306 0.0003
508 GASTRIC HAEMORRHAGE 4 0.0003
509 RALES 2 0.0003
510 ANAPHYLACTIC REACTION 19 0.0003
511 VASCULITIS 4 0.0003
512 ABORTION 1 0.0003
513 LUNG INFILTRATION 3 0.0003
514 HAEMOLYTIC ANAEMIA 3 0.0003
515 BLOOD CULTURE POSITIVE 1 0.0003
516 MOUTH ULCERATION 7 0.0003
517 HEPATITIS B 2 0.0003
518 LEUKOCYTOSIS 6 0.0003
519 APHASIA 10 0.0003
520 BONE MARROW DISORDER 1 0.0003
521 CHEST X-RAY ABNORMAL 1 0.0003
522 SMALL INTESTINAL OBSTRUCTION 4 0.0003
523 MENTAL STATUS CHANGES 9 0.0003
524 PIGMENTATION DISORDER 2 0.0003
525 OLIGURIA 2 0.0003
526 RENAL IMPAIRMENT 27 0.0003
527 BLOOD CREATININE DECREASED 1 0.0003
528 HAEMATOTOXICITY 3 0.0003
529 TREATMENT FAILURE 26 0.0003
530 HEPATITIS 8 0.0003
531 NEUTROPENIA 42 0.0003
532 HERPES SIMPLEX 2 0.0003
533 CHOKING 6 0.0003
534 HYPOGAMMAGLOBULINAEMIA 2 0.0003
535 CYTOLYTIC HEPATITIS 1 0.0003
536 COAGULOPATHY 5 0.0003
537 DRUG LEVEL DECREASED 3 0.0003
538 DRUG INEFFECTIVE 388 0.0003
539 CIRCULATORY COLLAPSE 5 0.0003
540 ABNORMAL LOSS OF WEIGHT 2 0.0003
541 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
542 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
543 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
544 ECCHYMOSIS 2 0.0003
545 PAIN 179 0.0003
546 APLASIA PURE RED CELL 1 0.0003
547 MULTI-ORGAN FAILURE 5 0.0003
548 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
549 PETECHIAE 3 0.0003
550 DEHYDRATION 38 0.0003
551 COLD SWEAT 5 0.0003
552 BLINDNESS UNILATERAL 4 0.0003
553 BONE EROSION 1 0.0003
554 RETINAL HAEMORRHAGE 2 0.0003
555 RED BLOOD CELL COUNT DECREASED 8 0.0003
556 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
557 OESOPHAGITIS 3 0.0003
558 VOMITING 129 0.0003
559 OSTEONECROSIS 9 0.0003
560 ASPIRATION 3 0.0003
561 ASTHMATIC CRISIS 1 0.0003
562 PSYCHIATRIC SYMPTOM 2 0.0003
563 HYPOPHOSPHATAEMIA 2 0.0003
564 CEREBRAL DISORDER 2 0.0003
565 MUCOSAL INFLAMMATION 7 0.0003
566 PREMATURE BABY 8 0.0003
567 AUTOIMMUNE THYROIDITIS 1 0.0003
568 MYOCARDIAL ISCHAEMIA 3 0.0003
569 HYPERTHERMIA 2 0.0003
570 EPILEPSY 8 0.0003
571 COMMUNICATION DISORDER 1 0.0003
572 SEIZURE 30 0.0003
573 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
574 DELIRIUM 9 0.0003
575 HYPOALBUMINAEMIA 2 0.0003
576 OCULAR HYPERAEMIA 12 0.0003
577 BLOOD ALBUMIN DECREASED 2 0.0003
578 TRANSPLANT REJECTION 2 0.0002
579 TOXICITY TO VARIOUS AGENTS 42 0.0002
580 CYSTITIS HAEMORRHAGIC 1 0.0002
581 DISCOMFORT 15 0.0002
582 SHOCK HAEMORRHAGIC 2 0.0002
583 ABNORMAL FAECES 2 0.0002
584 DEMYELINATION 1 0.0002
585 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
586 ACUTE KIDNEY INJURY 37 0.0002
587 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
588 MENSTRUAL DISORDER 2 0.0002
589 ILEUS 3 0.0002
590 VISUAL ACUITY REDUCED 8 0.0002
591 OEDEMA 13 0.0002
592 ASTHENIA 90 0.0002
593 URINARY INCONTINENCE 7 0.0002
594 BUNDLE BRANCH BLOCK LEFT 1 0.0002
595 LOSS OF CONSCIOUSNESS 30 0.0002
596 ABNORMAL SENSATION IN EYE 1 0.0002
597 FATIGUE 181 0.0002
598 RASH GENERALISED 6 0.0002
599 PYELONEPHRITIS 2 0.0002
600 PRODUCT PRESCRIBING ISSUE 5 0.0002
601 ABDOMINAL PAIN 53 0.0002
602 ABNORMAL BEHAVIOUR 9 0.0002
603 DRUG INTERACTION 36 0.0002
604 LIVER DISORDER 10 0.0002
605 ANAEMIA 43 0.0002
606 SKIN EXFOLIATION 19 0.0002
607 TACHYCARDIA 20 0.0002
608 EYE HAEMORRHAGE 3 0.0002
609 RASH MACULO-PAPULAR 5 0.0002
610 ORAL PAIN 5 0.0002
611 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
612 ASTHMA 25 0.0002
613 PERIPHERAL COLDNESS 3 0.0002
614 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
615 RETINAL DETACHMENT 2 0.0002
616 SHOCK 5 0.0002
617 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
618 HEPATIC FUNCTION ABNORMAL 8 0.0002
619 BRONCHOSPASM 3 0.0002
620 LIVER FUNCTION TEST ABNORMAL 6 0.0002
621 THROMBOCYTOPENIA 23 0.0002
622 HAEMORRHOIDS 4 0.0002
623 ALOPECIA 40 0.0002
624 HEPATOMEGALY 2 0.0002
625 BREATH SOUNDS ABNORMAL 1 0.0002
626 DECREASED APPETITE 47 0.0002
627 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
628 TREATMENT NONCOMPLIANCE 11 0.0002
629 ANEURYSM 1 0.0002
630 APPLICATION SITE SWELLING 1 0.0002
631 PREGNANCY 4 0.0002
632 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
633 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
634 HAEMATEMESIS 5 0.0002
635 VISION BLURRED 27 0.0002
636 SUBARACHNOID HAEMORRHAGE 2 0.0002
637 AMMONIA INCREASED 1 0.0002
638 EYE PAIN 11 0.0002
639 UNRESPONSIVE TO STIMULI 5 0.0002
640 BLOOD CHOLESTEROL INCREASED 9 0.0002
641 TOOTH LOSS 4 0.0002
642 NERVOUS SYSTEM DISORDER 6 0.0002
643 TENDERNESS 2 0.0002
644 CARDIO-RESPIRATORY ARREST 8 0.0002
645 RESTLESSNESS 7 0.0002
646 CATATONIA 1 0.0002
647 SCRATCH 2 0.0002
648 SUDDEN DEATH 2 0.0002
649 COMPRESSION FRACTURE 1 0.0002
650 ANAL FISSURE 1 0.0002
651 BRUXISM 1 0.0002
652 COLITIS 7 0.0002
653 FAECES DISCOLOURED 4 0.0002
654 PALLOR 5 0.0002
655 GASTROINTESTINAL PAIN 2 0.0002
656 TOOTH FRACTURE 2 0.0002
657 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
658 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
659 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
660 NEPHROPATHY TOXIC 2 0.0002
661 BLISTER 10 0.0002
662 FACE OEDEMA 3 0.0002
663 STATUS EPILEPTICUS 2 0.0002
664 REBOUND EFFECT 2 0.0002
665 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
666 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
667 MYOCARDITIS 2 0.0002
668 INFLAMMATION 9 0.0002
669 OEDEMA PERIPHERAL 21 0.0002
670 LOCAL SWELLING 3 0.0002
671 CHOLECYSTITIS 2 0.0002
672 MYOCLONUS 2 0.0002
673 PRODUCTIVE COUGH 8 0.0002
674 HYPERLIPIDAEMIA 2 0.0002
675 SPINAL OPERATION 2 0.0002
676 CONJUNCTIVITIS 3 0.0002
677 CHOLANGITIS 1 0.0002
678 ABDOMINAL PAIN UPPER 33 0.0002
679 INTENTIONAL PRODUCT MISUSE 14 0.0002
680 HEPATIC CIRRHOSIS 3 0.0002
681 PRURITUS 61 0.0002
682 GAIT DISTURBANCE 30 0.0002
683 LETHARGY 9 0.0002
684 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
685 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
686 DRUG RESISTANCE 4 0.0002
687 BREAST CANCER STAGE III 1 0.0002
688 DIPLOPIA 4 0.0002
689 ABDOMINAL DISTENSION 16 0.0002
690 NODULE 2 0.0002
691 PULMONARY CONGESTION 2 0.0002
692 CORONAVIRUS INFECTION 1 0.0002
693 APPETITE DISORDER 1 0.0002
694 ADVERSE REACTION 2 0.0002
695 CARDIAC FAILURE ACUTE 1 0.0001
696 PAIN OF SKIN 4 0.0001
697 DYSKINESIA 6 0.0001
698 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
699 PNEUMONITIS 4 0.0001
700 IMPAIRED GASTRIC EMPTYING 2 0.0001
701 HALLUCINATION 11 0.0001
702 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
703 ORAL DISCOMFORT 2 0.0001
704 RHABDOMYOLYSIS 6 0.0001
705 FEELING COLD 4 0.0001
706 LUNG DISORDER 7 0.0001
707 BLOOD TEST ABNORMAL 2 0.0001
708 HALLUCINATION, VISUAL 3 0.0001
709 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
710 LYMPHOPENIA 2 0.0001
711 LYMPHADENOPATHY 5 0.0001
712 MYALGIA 24 0.0001
713 SINUS TACHYCARDIA 2 0.0001
714 HYPERSENSITIVITY 26 0.0001
715 AGGRESSION 7 0.0001
716 PARALYSIS 2 0.0001
717 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
718 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
719 DIARRHOEA 90 0.0001
720 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
721 BALANCE DISORDER 12 0.0001
722 DRUG EFFECT INCOMPLETE 5 0.0001
723 DYSURIA 5 0.0001
724 PSYCHOTIC DISORDER 4 0.0001
725 DISEASE PROGRESSION 16 0.0001
726 EYE SWELLING 5 0.0001
727 RESPIRATORY DISORDER 4 0.0001
728 HEPATIC ENZYME INCREASED 9 0.0001
729 OSTEOPENIA 2 0.0001
730 DIZZINESS 65 0.0001
731 DEVICE RELATED INFECTION 2 0.0001
732 CONGENITAL ANOMALY 1 0.0001
733 DELUSION 2 0.0001
734 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
735 THERAPY PARTIAL RESPONDER 2 0.0001
736 PNEUMONIA 41 0.0001
737 DRUG SCREEN POSITIVE 1 0.0001
738 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
739 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
740 DISORIENTATION 5 0.0001
741 RESPIRATORY TRACT CONGESTION 2 0.0001
742 ULCER 2 0.0001
743 HYPOTHYROIDISM 4 0.0001
744 SENSORY DISTURBANCE 2 0.0001
745 MENTAL IMPAIRMENT 3 0.0001
746 MUSCLE TIGHTNESS 2 0.0001
747 CEREBRAL INFARCTION 3 0.0001
748 DECUBITUS ULCER 1 0.0001
749 BLINDNESS 5 0.0001
750 AGITATION 9 0.0001
751 MULTIPLE FRACTURES 2 0.0001
752 STAPHYLOCOCCAL INFECTION 4 0.0001
753 PHOTOSENSITIVITY REACTION 2 0.0001
754 ACUTE CORONARY SYNDROME 1 0.0001
755 VIRAL INFECTION 4 0.0001
756 PNEUMONIA ASPIRATION 3 0.0001
757 SYNCOPE 12 0.0001
758 GAIT INABILITY 4 0.0001
759 BLOOD UREA INCREASED 2 0.0001
760 CHILLS 14 0.0001
761 HEMIPARESIS 2 0.0001
762 HAEMOGLOBIN DECREASED 12 0.0001
763 ANURIA 1 0.0001
764 ORTHOSTATIC HYPOTENSION 2 0.0001
765 SPEECH DISORDER 6 0.0001
766 HYPOXIA 4 0.0001
767 DRUG ERUPTION 2 0.0001
768 CARDIOTOXICITY 1 0.0001
769 PULMONARY OEDEMA 5 0.0001
770 ANAL INCONTINENCE 1 0.0001
771 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
772 HAEMOPTYSIS 3 0.0001
773 SWELLING FACE 7 0.0001
774 HEPATIC STEATOSIS 2 0.0001
775 BLOOD CREATININE INCREASED 7 0.0001
776 BACTERIAL INFECTION 2 0.0001
777 APPENDICITIS 1 0.0001
778 SWELLING 10 0.0001
779 OXYGEN SATURATION DECREASED 6 0.0001
780 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
781 PHOTOPHOBIA 2 0.0001
782 BLOOD SODIUM DECREASED 2 0.0001
783 HYPOCALCAEMIA 2 0.0001
784 FEBRILE NEUTROPENIA 7 0.0001
785 GASTRIC ULCER 2 0.0001
786 PROTEINURIA 2 0.0001
787 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
788 EAR PAIN 2 0.0001
789 AUTOIMMUNE DISORDER 1 0.0001
790 BODY TEMPERATURE DECREASED 1 0.0001
791 DISABILITY 2 0.0001
792 HEPATIC FAILURE 3 0.0001
793 THERAPEUTIC RESPONSE DECREASED 6 0.0001
794 NAUSEA 78 0.0001
795 NEUTROPHIL COUNT DECREASED 4 0.0001
796 BODY TEMPERATURE INCREASED 2 0.0001
797 CARDIAC ARREST 8 0.0001
798 RHEUMATOID ARTHRITIS 11 0.0001
799 MUSCULAR WEAKNESS 11 0.0001
800 PERITONITIS 2 0.0001
801 PRODUCT USE ISSUE 18 0.0001
802 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
803 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
804 EATING DISORDER 2 0.0001
805 MOVEMENT DISORDER 3 0.0001
806 IRRITABLE BOWEL SYNDROME 2 0.0001
807 DRUG INTOLERANCE 9 0.0001
808 BREAST CANCER METASTATIC 1 0.0001
809 UNEVALUABLE EVENT 7 0.0001
810 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
811 DENTAL CARIES 1 0.0001
812 SKIN DISORDER 3 0.0001
813 GASTROINTESTINAL DISORDER 8 0.0001
814 EYE PRURITUS 3 0.0001
815 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
816 PANCREATITIS ACUTE 2 0.0001
817 HYPONATRAEMIA 5 0.0001
818 ANGER 3 0.0001
819 SKIN IRRITATION 4 0.0001
820 SKIN DISCOLOURATION 4 0.0001
821 CAESAREAN SECTION 1 0.0001
822 RASH MACULAR 3 0.0001
823 ATAXIA 1 0.0001
824 PRODUCT PRESCRIBING ERROR 2 0.0001
825 OVERDOSE 18 0.0001
826 BLOOD GLUCOSE DECREASED 4 0.0001
827 MYELOSUPPRESSION 3 0.0001
828 IRRITABILITY 5 0.0001
829 BURSITIS 1 0.0001
830 HYPERGLYCAEMIA 3 0.0001
831 INFLUENZA 9 0.0001
832 DYSARTHRIA 3 0.0001
833 DERMATITIS ALLERGIC 1 0.0001
834 ABDOMINAL PAIN LOWER 2 0.0001
835 PRODUCT COMPLAINT 2 0.0001
836 TREMOR 13 0.0001
837 DEATH 67 0.0001
838 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
839 ANAPHYLACTIC SHOCK 2 0.0001
840 RESPIRATORY TRACT INFECTION 2 0.0001
841 APPLICATION SITE ERYTHEMA 2 0.0001
842 ANHEDONIA 2 0.0001
843 BEDRIDDEN 1 0.0001
844 RENAL FAILURE 10 0.0001
845 PLATELET COUNT DECREASED 8 0.0001
846 HYPOTENSION 15 0.0001
847 DISTURBANCE IN ATTENTION 4 0.0001
848 RASH PRURITIC 4 0.0001
849 DYSPHAGIA 7 0.0001
850 DRUG TOXICITY 1 0.0001
851 OSTEOPOROSIS 3 0.0001
852 ABNORMAL DREAMS 2 0.0001
853 ARTHROPATHY 4 0.0001
854 URTICARIA 12 0.0001
855 NECK PAIN 4 0.0001
856 WOUND 2 0.0001
857 CARPAL TUNNEL SYNDROME 1 0.0001
858 HEART RATE INCREASED 7 0.0001
859 NASOPHARYNGITIS 13 0.0001
860 HYPERHIDROSIS 9 0.0001
861 SKIN BURNING SENSATION 5 0.0001
862 HYPERSOMNIA 2 0.0001
863 VAGINAL HAEMORRHAGE 3 0.0001
864 MENTAL DISORDER 3 0.0001
865 CONSTIPATION 15 0.0001
866 APATHY 1 0.0001
867 ASCITES 2 0.0001
868 ANGIOEDEMA 3 0.0001
869 COLON CANCER 1 0.0001
870 HAEMORRHAGE 7 0.0001
871 LACRIMATION INCREASED 2 0.0001
872 BLOOD COUNT ABNORMAL 1 0.0001
873 ACNE 5 0.0001
874 DIABETES MELLITUS 5 0.0001
875 MEMORY IMPAIRMENT 9 0.0001
876 DRUG ADMINISTRATION ERROR 2 0.0001
877 ARTHRALGIA 27 0.0001
878 ANKLE FRACTURE 1 0.0001
879 RENAL DISORDER 3 0.0001
880 BONE DENSITY DECREASED 2 0.0001
881 BRAIN FOG 1 0.0001
882 ARRHYTHMIA 3 0.0001
883 RASH ERYTHEMATOUS 3 0.0001
884 DRY MOUTH 5 0.0001
885 CHOLELITHIASIS 2 0.0001
886 EYE DISORDER 2 0.0001
887 FUNGAL INFECTION 2 0.0001
888 URINARY RETENTION 2 0.0001
889 CANDIDA INFECTION 1 0.0001
890 BLOOD PRESSURE INCREASED 9 0.0001
891 ILLNESS 6 0.0001
892 PARAESTHESIA 9 0.0001
893 BURNING SENSATION 4 0.0001
894 INJURY 4 0.0001
895 DEPRESSED MOOD 3 0.0001
896 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
897 DYSPNOEA 32 0.0001
898 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
899 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
900 INFECTION 8 0.0001
901 BONE DISORDER 1 0.0001
902 UNDERDOSE 4 0.0001
903 ADVERSE EVENT 5 0.0001
904 HYPOAESTHESIA 8 0.0001
905 BLOOD URINE PRESENT 1 0.0001
906 CHRONIC KIDNEY DISEASE 4 0.0001
907 NEUROPATHY PERIPHERAL 5 0.0001
908 HERPES ZOSTER 3 0.0001
909 DRUG PRESCRIBING ERROR 1 0.0001
910 CARDIAC FAILURE 4 0.0000
911 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
912 ANXIETY 14 0.0000
913 FEELING HOT 3 0.0000
914 VISUAL IMPAIRMENT 6 0.0000
915 MALAISE 21 0.0000
916 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
917 AMNESIA 3 0.0000
918 PSORIASIS 6 0.0000
919 FEELING ABNORMAL 11 0.0000
920 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
921 PERIPHERAL SWELLING 7 0.0000
922 ERYTHEMA 9 0.0000
923 CHEST PAIN 8 0.0000
924 COGNITIVE DISORDER 2 0.0000
925 COUGH 12 0.0000
926 FALL 14 0.0000
927 MULTIPLE SCLEROSIS 2 0.0000
928 HYPOGLYCAEMIA 2 0.0000
929 DYSPEPSIA 4 0.0000
930 BRONCHITIS 3 0.0000
931 EPISTAXIS 3 0.0000
932 CELLULITIS 2 0.0000
933 CHEST DISCOMFORT 4 0.0000
934 THERAPY CESSATION 2 0.0000
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
936 DEAFNESS 1 0.0000
937 DRUG ABUSE 3 0.0000
938 FLATULENCE 2 0.0000
939 ANGINA PECTORIS 1 0.0000
940 EYE IRRITATION 2 0.0000
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
942 DYSPHONIA 2 0.0000
943 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
944 NASAL CONGESTION 2 0.0000
945 ACUTE MYOCARDIAL INFARCTION 1 0.0000
946 BLOOD POTASSIUM DECREASED 1 0.0000
947 HYPERTENSION 7 0.0000
948 PLEURAL EFFUSION 2 0.0000
949 SUICIDAL IDEATION 3 0.0000
950 OROPHARYNGEAL PAIN 3 0.0000
951 WEIGHT INCREASED 7 0.0000
952 INTENTIONAL OVERDOSE 2 0.0000
953 RHINORRHOEA 2 0.0000
954 INCORRECT DOSE ADMINISTERED 7 0.0000
955 BLOOD PRESSURE DECREASED 2 0.0000
956 INSOMNIA 8 0.0000
957 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
958 PRODUCT QUALITY ISSUE 4 0.0000
959 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
960 INJECTION SITE REACTION 2 0.0000
961 MYOCARDIAL INFARCTION 5 0.0000
962 DEVICE MALFUNCTION 2 0.0000
963 SLEEP DISORDER 2 0.0000
964 CEREBRAL HAEMORRHAGE 1 0.0000
965 MOBILITY DECREASED 2 0.0000
966 CRYING 1 0.0000
967 THROMBOSIS 2 0.0000
968 JOINT SWELLING 3 0.0000
969 EMOTIONAL DISTRESS 3 0.0000
970 DRUG DOSE OMISSION 4 0.0000
971 COMPLETED SUICIDE 2 0.0000
972 DRUG WITHDRAWAL SYNDROME 2 0.0000
973 MUSCLE SPASMS 4 0.0000
974 BACK PAIN 5 0.0000
975 CONTUSION 2 0.0000
976 ATRIAL FIBRILLATION 2 0.0000
977 PRODUCT DOSE OMISSION ISSUE 6 0.0000
978 FLUSHING 2 0.0000
979 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
980 HOSPITALISATION 3 0.0000
981 SINUSITIS 2 0.0000
982 DERMATITIS ATOPIC 1 0.0000
983 BRADYCARDIA 1 0.0000
984 DRUG EFFECT DECREASED 1 0.0000
985 URINARY TRACT INFECTION 3 0.0000
986 BONE PAIN 1 0.0000
987 INJECTION SITE PAIN 5 0.0000
988 CARDIAC FAILURE CONGESTIVE 1 0.0000
989 DRUG DEPENDENCE 2 0.0000
990 NO ADVERSE EVENT 2 0.0000
991 BREAST CANCER 1 0.0000
992 CARDIAC DISORDER 1 0.0000
993 BLOOD GLUCOSE INCREASED 2 0.0000